Actavis CEO: Teva-Mylan deal could be "value-destroying" - גלובס
Mylan Raises Offer for Perrigo Again and Is Rejected Again - The New York Times
Mylan shares soar after takeover proposal
Big blow for Teva as FDA approves Mylan's generic Copaxone - Globes
Teva drops bid for Mylan, buys Allergan's generics unit | Pittsburgh Post-Gazette
$40B deal: Teva offers to buy Mylan
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid | Reuters
Teva Issues New Letter to Mylan NV Confirming Seriousness Of Offer To Acquire Mylan - Jewish Business News
Mylan Should Try Teva On for Size - WSJ
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare IT News
US lawmakers push Mylan, Teva over drug pricing probe - www.israelhayom.com
Generic drugmaker Teva makes $40bn offer for rival Mylan
Teva's Copaxone holds its own in wake of Mylan's generic price cut | Fierce Pharma
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Israel-Based Teva Pharmaceutical Industries Smacks Down With Mylan With $40B Bid - YouTube
Teva gains leverage in pursuit of Mylan | Pittsburgh Post-Gazette
Teva Offers to acquire Mylan for $40 billion in cash, stock | Pharma Companies
How Mylan tried to keep Teva from selling a generic EpiPen
Drugmaker Teva makes $40B bid for rival Mylan
Teva offers to buy rival Mylan for $40 billion | Fortune
Teva Pharmaceutical Industries' quest to acquire Mylan NV could wind up in a Dutch court - Pittsburgh Business Times
Teva Pharmaceutical Industries Ltd. ends its hostile bid for Mylan NV - Pittsburgh Business Times
Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats | Fierce Pharma
Generic EpiPen Cleared By FDA As Teva Challenges Mylan
Mylan, Generic Copaxone Punish Teva (NYSE:TEVA) | Seeking Alpha
